Development and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCL
about
New insights into MicroRNAs involves in drug resistance in diffuse large B cell lymphomaCell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial DataNew developments in the pathology of malignant lymphoma: a review of literature published from January 2015 to April 2015.Clinical Impact of a Novel MicroRNA Chemo-Sensitivity Predictor in Gastrooesophageal Cancer.Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer.MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential.Current status on microRNAs as biomarkers for ovarian cancer.A 4-miRNA signature to predict survival in glioblastomas.Searching for new biomarkers in ovarian cancer patients: Rationale and design of a retrospective study under the Mermaid III project.Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study
P2860
Q26765273-8EC2924B-99D2-431D-9A24-4825DCE83959Q28552023-98AC0E20-32D1-45CF-A0B0-C1BB02264409Q35783447-A858240C-439C-47FB-B367-89E42A802C1FQ35925992-4F76E660-C5B8-4A7E-8D31-DD32A9BA01A5Q36320168-372A5076-EC6C-479C-B215-59559EF962C1Q38599607-2E1A32A0-25B4-4CF2-868E-583BF97D1D07Q38711390-410D3D22-1875-4FAF-8938-F2CD27F266ACQ47136071-82302E19-DB6C-438E-9010-2E84AA2C8EFDQ52562510-D32F6B04-33F1-40F0-A191-2E32E34D32D8Q56523625-A28077BA-7BE6-40A3-88A1-6D0C27665295
P2860
Development and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCL
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Development and blind clinical ...... atment with R-CHO(E)P in DLBCL
@ast
Development and blind clinical ...... atment with R-CHO(E)P in DLBCL
@en
Development and blind clinical ...... atment with R-CHO(E)P in DLBCL
@nl
type
label
Development and blind clinical ...... atment with R-CHO(E)P in DLBCL
@ast
Development and blind clinical ...... atment with R-CHO(E)P in DLBCL
@en
Development and blind clinical ...... atment with R-CHO(E)P in DLBCL
@nl
prefLabel
Development and blind clinical ...... atment with R-CHO(E)P in DLBCL
@ast
Development and blind clinical ...... atment with R-CHO(E)P in DLBCL
@en
Development and blind clinical ...... atment with R-CHO(E)P in DLBCL
@nl
P2093
P2860
P50
P3181
P1433
P1476
Development and blind clinical ...... atment with R-CHO(E)P in DLBCL
@en
P2093
Anker Hansen
Christoffer Hother
Elizabeth Ralfkiær
Peter de Nully Brown
Steen Knudsen
Thomas Jensen
Wiktor Mazin
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0115538
P407
P577
2015-01-01T00:00:00Z